85 related articles for article (PubMed ID: 15567157)
1. NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates beta-catenin expression.
Nath N; Labaze G; Rigas B; Kashfi K
Biochem Biophys Res Commun; 2005 Jan; 326(1):93-9. PubMed ID: 15567157
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention.
Williams JL; Nath N; Chen J; Hundley TR; Gao J; Kopelovich L; Kashfi K; Rigas B
Cancer Res; 2003 Nov; 63(22):7613-8. PubMed ID: 14633677
[TBL] [Abstract][Full Text] [Related]
3. Modulation of stress genes expression profile by nitric oxide-releasing aspirin in Jurkat T leukemia cells.
Nath N; Chattopadhyay M; Kodela R; Tian S; Vlismas P; Boring D; Crowell JA; Kashfi K
Biochem Pharmacol; 2010 Jun; 79(12):1759-71. PubMed ID: 20188076
[TBL] [Abstract][Full Text] [Related]
4. Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo.
Kashfi K; Borgo S; Williams JL; Chen J; Gao J; Glekas A; Benedini F; Del Soldato P; Rigas B
J Pharmacol Exp Ther; 2005 Mar; 312(3):978-88. PubMed ID: 15528453
[TBL] [Abstract][Full Text] [Related]
5. Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.
Nath N; Vassell R; Chattopadhyay M; Kogan M; Kashfi K
Biochem Pharmacol; 2009 Nov; 78(10):1298-304. PubMed ID: 19576865
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association.
Nath N; Kashfi K; Chen J; Rigas B
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12584-9. PubMed ID: 14566053
[TBL] [Abstract][Full Text] [Related]
7. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
Konturek PC; Kania J; Burnat G; Hahn EG
J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of action of nitric oxide-donating aspirin.
Kashfi K; Rigas B
Biochem Biophys Res Commun; 2007 Jul; 358(4):1096-101. PubMed ID: 17512900
[TBL] [Abstract][Full Text] [Related]
9. Molecular targets of nitric-oxide-donating aspirin in cancer.
Kashfi K; Rigas B
Biochem Soc Trans; 2005 Aug; 33(Pt 4):701-4. PubMed ID: 16042578
[TBL] [Abstract][Full Text] [Related]
10. [Indomethacin-induced HL-60 cell apoptosis is associated with inhibition of beta-catenin/c-myc signal transduction pathway].
Zhang GS; Wang ZY
Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):629-31. PubMed ID: 14761609
[TBL] [Abstract][Full Text] [Related]
11. NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR)delta expression in APC(min/+) mice proportionally to their tumor inhibitory effect: Implications for the role of PPARdelta in carcinogenesis.
Ouyang N; Williams JL; Rigas B
Carcinogenesis; 2006 Feb; 27(2):232-9. PubMed ID: 16141240
[TBL] [Abstract][Full Text] [Related]
12. Diclofenac attenuates Wnt/beta-catenin signaling in colon cancer cells by activation of NF-kappaB.
Cho M; Gwak J; Park S; Won J; Kim DE; Yea SS; Cha IJ; Kim TK; Shin JG; Oh S
FEBS Lett; 2005 Aug; 579(20):4213-8. PubMed ID: 16051228
[TBL] [Abstract][Full Text] [Related]
13. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by Chan Su, a traditional Chinese medicine, in human bladder carcinoma T24 cells.
Ko WS; Park TY; Park C; Kim YH; Yoon HJ; Lee SY; Hong SH; Choi BT; Lee YT; Choi YH
Oncol Rep; 2005 Aug; 14(2):475-80. PubMed ID: 16012733
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-donating acetylsalicylic acid induces apoptosis in chronic lymphocytic leukemia cells and shows strong antitumor efficacy in vivo.
Razavi R; Gehrke I; Gandhirajan RK; Poll-Wolbeck SJ; Hallek M; Kreuzer KA
Clin Cancer Res; 2011 Jan; 17(2):286-93. PubMed ID: 21097689
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model.
Ouyang N; Williams JL; Tsioulias GJ; Gao J; Iatropoulos MJ; Kopelovich L; Kashfi K; Rigas B
Cancer Res; 2006 Apr; 66(8):4503-11. PubMed ID: 16618778
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression.
Chattopadhyay M; Nath N; Kodela R; Sobocki T; Metkar S; Gan ZY; Kashfi K
Leuk Res; 2013 Oct; 37(10):1302-8. PubMed ID: 23896061
[TBL] [Abstract][Full Text] [Related]
18. NO-donating aspirin inhibits both the expression and catalytic activity of inducible nitric oxide synthase in HT-29 human colon cancer cells.
Spiegel A; Hundley TR; Chen J; Gao J; Ouyang N; Liu X; Go MF; Tsioulias GJ; Kashfi K; Rigas B
Biochem Pharmacol; 2005 Oct; 70(7):993-1000. PubMed ID: 16105666
[TBL] [Abstract][Full Text] [Related]
19. Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling.
Vannini F; Chattopadhyay M; Kodela R; Rao PPN; Kashfi K
Redox Biol; 2015 Dec; 6():318-325. PubMed ID: 26319435
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of mesenchymal stem cells by aspirin: involvement of the WNT/beta-catenin signal pathway.
Wang Y; Chen X; Zhu W; Zhang H; Hu S; Cong X
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):696-701. PubMed ID: 16895542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
